Newsletter | January 12, 2026

01.12.26 -- The Hidden Work That Keeps AMC Trials Moving

SPONSOR

Live Event: The FDA Year in Review — And What Comes Next

The FDA didn’t sit still in 2025, and neither can you. Our industry insider panelists will cut through the noise to explain which regulatory shifts, guidance updates, and inspection trends really matter for clinical trials in 2026 — and what you should do about them. Click here to learn more.

PATIENT CENTRICITY

Patient Input Is A Must — Even Under Time And Money Constraints

Guest Column | A conversation with Stacie J. Bell, Ph.D., Lupus Therapeutics

Stacie J. Bell, Ph.D., discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.

Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials

Article | CHDR

Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.

How To Measure Patient Experience In Clinical Studies

Webinar | Jumo Health

This session provides a clear roadmap for transforming patient experience into a measurable engine for growth using maturity assessment, friction mapping, and business value modeling.

PATIENT RECRUITMENT

Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025

Guest Column | By Abby Proch, executive editor, Clinical Leader

Researchers reflect on the past year and share how they used AI for clinical research in 2025.

9 Strategies To Increase Enrollment In Clinical Trials

Article | AutoCruitment

An effective participant enrollment strategy is crucial to ensuring clinical trial success and avoiding missed deadlines, increased costs, and flawed trial outcomes.

Living With An Invisible Disease: One Woman's Journey With CF

Article | Mural Health

Meet a clinical research participant who has spent her life navigating the challenges of cystic fibrosis, leading her to become an advocate, amplifying the voices of others facing similar struggles.

CLINICAL SITES

The Hidden Work That Keeps AMC Trials Moving

From The Editor | By Dan Schell, chief editor, Clinical Leader

After a chance LinkedIn connection led to a conversation with Paul Antaby of MD Anderson, I got an inside look at how clinical trials really operate inside a major academic medical center. From material transfer agreements and data governance to recruitment, scale, and CRC burnout, this interview reveals the hidden work that keeps AMC trials moving — and why they operate so differently from community sites.

Accelerating Site Activation: Examples From Novartis And IQVIA

Article | By Rosemary Shirey, IQVIA Technologies

As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

Safe-To-Site Initiative

Brochure | Block Clinical Inc.

By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: